Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure

Last updated: April 8, 2025
Sponsor: Johns Hopkins University
Overall Status: Active - Not Recruiting

Phase

1

Condition

Skin Aging

Treatment

UV or visible light

Sulforaphane (broccoli sprout extract)

Clinical Study ID

NCT03730649
IRB00184806
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The study is to compare the expression of both keratin 16 and 17 before and after application of sulforaphane on both photoprotected and photoexposed area, and to determine whether these findings alter skin aging as well as skin response to ultraviolet (UV) and visible light exposure.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Participants must be over the age of 18 years old with healthy skin or moderatedegree of photoaging/intrinsic aging;

  • Must be healthy enough to undergo skin biopsy, light irradiation, and other studyprocedures in the opinion of the investigator;

  • Must be willing to comply with the requirements of the protocol;

  • Must have the ability to understand and communicate with the investigator;

  • Participant must provide informed consent.

Exclusion

Exclusion Criteria:

  • Subjects who are unable to provide informed consent;

  • Subject with significant medical history or current skin diseases that theinvestigator feels is not safe for study participation;

  • Subjects who have been treated with systemic retinoids or steroids within the pastmonth prior to entry to the study;

  • Subjects who have been treated with topical steroids, retinoids or other topicaldrugs used within 2 weeks prior to entry to the study;

  • Recently treated or current skin diseases that would affect clinical evaluation andbiopsy;

  • Subjects with a known allergy to broccoli.

  • Presence or suspicion of bleeding disorder or diathesis which would complicatebiopsy.

  • Subjects with a history of excessive scar or keloid formation in the past 10 years.

  • Pregnant or nursing subjects (self-reported).

  • Subjects with known allergy to anesthetics used.

  • Patients with history of investigational drug use in the 30 days prior to entry intothe study.

Study Design

Total Participants: 12
Treatment Group(s): 2
Primary Treatment: UV or visible light
Phase: 1
Study Start date:
October 09, 2019
Estimated Completion Date:
April 30, 2026

Study Description

The study is to compare the expression of both keratin 16 and 17 before and after application of sulforaphane on both photoprotected and photoexposed area, and to determine whether these findings alter skin aging as well as skin response to ultraviolet (UV) and visible light exposure.

Each study participant will have up to eight study visits. Topical sulforaphane will be applied for up to 6 months. Photography, clinical assessment, UV light irradiation, Visible light treatment, Skin biopsies, non invasive elasticity measurements such as cutometer and ballistometer, and others will be involved in this study.

Connect with a study center

  • Cutaneous Translational Research Program, Department of Dermatology, Johns Hopkins University School of Medicine

    Baltimore, Maryland 21287
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.